A. Eskiturk et al., THE EFFECTS OF EXPERIMENTAL SPLENIC AUTOTRANSPLANTATION AND IMIPENEM-CILASTATIN TREATMENT IN POSTSPLENECTOMY PSEUDOMONAS-AERUGINOSA SEPSIS, Research in experimental medicine, 195(3), 1995, pp. 163-169
Male Wistar albino rats were allocated to three groups - sham operated
(n: 10), splenectomized (n: 20) and splenic autotransplanted (n: 10).
Twelve weeks after operation, all were challenged with 1.8 x 10(8) cf
u/ml Pseudomonas aeruginosa intranasally. Half of the splenectomized r
ats received imipenem-cilastatin after 2 h of bacterial challenge. Mor
tality was then observed for the next 12 days. All animals were autops
ied and liver, kidney, spleen and lung specimens were processed for mi
crobiological culture and histopathological examination. In 80% of aut
otransplanted rats, splenic tissue regeneration was histopathologicall
y verified. Hemoglobin oxidation of erythrocytes increased in splenect
omized rats and remained close to control levels in the autotransplant
ed group. No significant difference was detected between IgM levels of
splenectomized and autotransplanted groups. Mortality rates were the
same for all groups, except that splenectomized animals given antimicr
obial therapy had increased survival rates. In conclusion, it is likel
y that the spleen has no role in protection against pulmonary sepsis a
nd that only appropriate antimicrobial therapy can protect the splenec
tomized host from Pseudomonas sepsis.